We are pleased to announce that Groombridge, Wu, Baughman & Stone LLP has been named Benchmark Litigation’s “Intellectual Property Firm of the Year” for 2024. The annual award recognizes the country’s most distinguished law firms for their exemplary work in intellectual property litigation over the past year.

The win, announced at the Benchmark Litigation US Awards 2024 in New York City on March 13, 2024, comes just four months after Groombridge Wu’s one-year anniversary. Since its founding in November 2022, the firm has secured major victories on behalf of clients, including Novo Nordisk for its blockbuster diabetes and obesity drug treatments and Genentech for a breakthrough Hemophilia A treatment. The honor reflects the market’s recognition of the firm’s leading role in intellectual property litigation—whether in courts, arbitrations, the International Trade Commission, or before the Patent Trial and Appeal Board. 

Groombridge Wu’s lawyers have been ranked in Chambers, the Legal 500, the IAM Patent 1000, Managing IP, and Lawdragon’s 500 Leading Global Litigators list. In October 2023, five Groombridge Wu partners were recognized individually in the 2024 edition of Benchmark Litigation. Nick Groombridge, Steven Baughman, and Eric Stone were named “Litigation Stars,” and Jennifer Wu and Megan Raymond were named “Future Stars.”